Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 3/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.52 |
| ▸ | FNTA | P49354 | 5/20 | 0.50 |
| ▸ | FNTB | P49356 | 3/20 | 0.50 |
| ▸ | SQLE | Q14534 | 2/20 | 0.50 |
| ▸ | PGGT1B | P53609 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL560299 | 1.00 | ALOX15 (0.58) | ALOX15ALDH1A1KMT2AMEN1CYP3A4 | |
| SCHEMBL358273 | 1.00 | ALOX15 (0.58) | ALOX15ALDH1A1KMT2AMEN1CYP3A4 | |
| SCHEMBL1704546 | 0.98 | KMT2A (0.61) | ALOX15ALDH1A1KMT2AMEN1CYP3A4 | |
| SCHEMBL15370334 | 0.98 | KMT2A (0.61) | ALOX15ALDH1A1KMT2AMEN1CYP3A4 | |
| Water SCHEMBL9744752 | 0.98 | ALOX15 (0.56) | ALOX15ALDH1A1KMT2AMEN1CYP3A4 | |
| SCHEMBL6442169 | 0.98 | KMT2A (0.61) | ALOX15ALDH1A1KMT2AMEN1CYP3A4 | |
| SCHEMBL14077034 | 0.98 | KMT2A (0.61) | ALOX15ALDH1A1KMT2AMEN1CYP3A4 | |
| SCHEMBL6442176 | 0.98 | KMT2A (0.61) | ALOX15ALDH1A1KMT2AMEN1CYP3A4 | |
| Ether SCHEMBL9744748 | 0.94 | ALOX15 (0.56) | ALOX15ALDH1A1KMT2AMEN1CYP3A4 | |
| Nerol SCHEMBL458984 | 0.93 | ALOX15 (0.68) | ALOX15ALDH1A1KMT2AMEN1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 296 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12496370-B2 | Freshening compositions comprising controlled release modulators | Arylessence, Inc. (US) | 2025-12-16 | — | — | US | claimed |
| CN-115885997-B | Large-grain transverse ditch image pheromone attractant and application thereof | 中国林业科学研究院森林生态环境与自然保护研究所 | 2024-04-02 | — | — | CN | claimed |
| US-11806448-B2 | Freshening compositions comprising controlled release modulators | Arylessence, Inc. (US) | 2023-11-07 | — | — | US | claimed |
| CN-115885997-A | Pheromone attractant for macroparticle transverse groove elephant and application thereof | 中国林业科学研究院森林生态环境与自然保护研究所 | 2023-04-04 | — | — | CN | claimed |
| CN-114196475-A | Ginger flower essence | 上海应用技术大学 | 2022-03-18 | — | — | CN | claimed |
| WO-2018145219-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ADDICTIONS BY MEANS OF AVERSIVE COUNTERCONDITIONING | SERANI MOSTAZAL JORGE (CL) | 2018-08-16 | — | — | WO | claimed |
| US-9200237-B2 | 4,8-dimethyl-4,9-decadienenitrile | KAO CORPORATION (JP) | 2015-12-01 | — | — | US | claimed |
| US-20060040218-A1 | Terpene ether solvents | WYATT MARION F | 2006-02-23 | — | — | US | claimed |
| EP-1088333-A4 | COMPOSITIONS AND METHODS FOR INHIBITING BONE RESORPTION | MERCK & CO INC (US) | 2005-08-10 | — | — | EP | claimed |
| US-6699850-B2 | ORAL FORMULATION OF A COMBINATION OF NITROGEN-CONTAINING BISPHOSPHONATE OR ITS SALT AND AN ISOPRENOID COMPOUND FOR INHIBITING BONE RESOPRTION IN A MAMMAL WHILE COUNTERACTING THE OCCURRENCE OF ADVERSE GASTROINTESTINAL EFFECT | MERCK & CO., INC. | 2004-03-02 | — | — | US | claimed |
| US-20020082244-A1 | Compositions and methods for inhibiting bone resorption | MERCK & CO., INC. | 2002-06-27 | — | — | US | claimed |
| EP-1088333-A1 | COMPOSITIONS AND METHODS FOR INHIBITING BONE RESORPTION | Merck & Co., Inc. (US) | 2001-04-04 | — | — | EP | claimed |
| WO-1999067809-A9 | COMPOSITIONS AND METHODS FOR INHIBITING BONE RESORPTION | MERCK & CO INC (US) | 2001-03-22 | — | — | WO | claimed |
| WO-1999067809-A1 | COMPOSITIONS AND METHODS FOR INHIBITING BONE RESORPTION | MERCK & CO., INC. (US) | 1999-12-29 | — | — | WO | claimed |
| US-5089162-A | Liquid or grains, lemon scent, yellow color; automatic dishwasher detergent | LEVER BROTHERS COMPANY, DIVISION OF CONOPCO, INC. (US) | 1992-02-18 | — | — | US | claimed |
| CN-87103789-A | Through improving the polydicyclopentadiene of smell | — | 1988-12-14 | — | — | CN | claimed |
| US-4731395-A | Polydicyclopentadiene having improved odor | HERCULES INCORPORATED (US) | 1988-03-15 | — | — | US | claimed |
| EP-0249032-A1 | Polydicyclopentadiene having improved odor | HERCULES INCORPORATED (US) | 1987-12-16 | — | — | EP | claimed |
| EP-3148345-B1 | METHOD FOR REFINING LIPID PHASES, AND USE | DREI LILIEN PVG GMBH&CO KG (DE) | 2026-04-29 | — | — | EP | disclosed |
| US-4117110-A | GELS, DEODORIZERS | GLOBOL WERK GMBH (DE) | 1978-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020082244-A1 | Compositions and methods for inhibiting bone resorption | SOST, PTEN, ALPI | ALOX15 441/4885ALDH1A1 4552/4885KMT2A 4503/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.